|
Welcome back to The Stratosphere.
First off, if you’ve got a colleague or friend who might enjoy these dispatches on Silicon Valley, politics and philanthropy, we’ve now made it easier than ever to sign up for The Stratosphere. All you need to do is forward them this note so they can drop their email right here. Feel free to share that link.
As a reminder, when you subscribe to Puck, you’ll also get full access to our website, exclusive events, and the work of all of my fantastic colleagues. If you’re enjoying The Stratosphere, after all, you might also be interested in previewing Dylan Byers’ biweekly email about media machinations at this link, or add your name to Julia Ioffe’s private list to receive her latest dispatches from Washington.
A few Tuesday thoughts…
The inside conversation about Silicon Valley’s favorite charity, MacKenzie Scott’s personnel debate, and Bezos’ latest effort to perfect his physique. For as long as I can remember, journalists and supposedly savvy observers have been reflexively dismissive, if not outright hostile, to Silicon Valley’s ongoing obsession with life-extension research. There is, after all, something seemingly contemptible—and a little bit funny—about billionaires wasting money on futile efforts to live forever. The very notion brings to mind the stories about Peter Thiel injecting himself with teenage blood (something he has denied), or Larry Ellison deadpanning that death just “never made any sense to me,” or Nick Bostrom and Ray Kurzweil signing up to have their bodies cryogenically frozen.
That’s not a stereotype: tech leaders have provided much of the funding in the life-extension field, through both philanthropy and for-profit investing. At a time when real people are suffering from more devastating problems—malnutrition in the developing world, Black maternal mortality in the United States, not to mention the latest strands of COVID-19—it can feel out of touch, even unseemly, to see very wealthy people focusing on the one thing they themselves cannot escape… death.
But that kneejerk skepticism can also lead folks to ignore the potential benefits of aging research, which could have major implications for our understanding of associated diseases like Parkinson’s and Alzheimer’s. Breakthroughs in the field would be an unalloyed good—for our families, for our loved ones, for the productivity of our economy (OK, maybe not for our entitlement budgets). Yes, there’s debate to be had about whether extending the lifespans of generally already-advantaged people—out of all the issues in human biology, never mind all the issues in the world—is society’s most pressing problem. Yet it’s equally silly, and inaccurate, to reduce the field to a bunch of Silicon Valley billionaires wanting to live forever.
All that context was on my mind with the much-anticipated public debut last week of Altos Labs, a new Silicon Valley biotechnology company dedicated to investigating (and reversing) aging. The most attention-grabbing headline, of course, was the budget: $3 billion, in what is said to be the largest biotech fundraising round ever. Some of the money comes from co-founder Yuri Milner, the Russian-Israeli entrepreneur who backed Facebook and is best known in philanthropy for using his billions to fund the Breakthrough Prize and its associated gala. The idea for Altos reportedly sprung from a series of conversations between Milner and biotech entrepreneur Rick Klausner, during their regular walks together through the Los Altos Hills. Intriguingly, another funder, reportedly and covertly, is Jeff Bezos, according to some great scoopage from MIT Technology Review.
Silicon Valley Philanthropy’s “Strategic Reset”
We’re beginning to see some tangible signs of change at the once-embattled Silicon Valley Community Foundation. SVCF is Silicon Valley’s favorite charity, housing the donor-advised funds of celebrities like Mark Zuckerberg and Pierre Omidyar. But insiders will recall—trust me, SVCF staff certainly recall—that the $13 billion institution was absolutely battered by scandal over the late 2010s. An investigation into its workplace culture ultimately resulted in the ouster of SVCF’s omnipresent, Rasputin-like C.E.O., Emmett Carson (who, predictably, landed on his feet just fine in Hollywood). But over the last few years, his more clairvoyant successor, Nicole Taylor, has calmed the waters, bringing in an almost entirely new management team and board (although, as DAF critics would note, not a new business model).
One long-standing criticism of SVCF has been that, for an organization called the Silicon Valley Community Foundation, the group didn’t seem to do a lot of, you know, foundationing in the community. Carson’s organization, with offices in New York and marquee projects in places like Ghana, became a poster child for rich techies who chased world-changing ideas while remaining callous to local issues. Taylor set out to change that, to “put the community back in community foundation,” as she liked to say, especially during the pandemic. And last week, we got some new data that, on the surface at least, suggests that Taylor has been successful: Last year, the group sent $777 million to Bay Area nonprofits, a record high.
But when you dig into the numbers, I’d argue Taylor’s advocacy has yet to move the dial. In 2017—Carson’s last, scandal-free full year as C.E.O.—$436 million of the $1.3 billion in grants from donors, or 34 percent, went to local orgs. In 2021, the record-breaking year for Taylor, and her third at the helm, the $777 million in local grants amounted to… 34 percent of the $2.2 billion in total grantmaking. “We are seeing the results of that strategic refresh now, and we will keep working to emphasize local, effective giving with our donors,” a SVCF spokesperson told me. “There’s no two ways about it—$777 million going to Bay Area nonprofits is a phenomenal illustration of generosity.” Tech donors are donating more everywhere, yes, but they aren’t actively shifting their bets. Taylor is widely admired by local nonprofit and philanthropy types, including, if you couldn’t tell, by me. But her push for local donations is not showing in the data yet.
On “Davos Man”
And Finally, Some Feedback…
FOUR STORIES WE'RE TALKING ABOUT With apologies to Wall Street, the streamer's stock price apocalypse is a market problem more than a business problem. MATTHEW BELLONI Despite the narrative, Trump and DeSantis don’t hate one another’s guts. Instead, they are involved in a more complex game theory. TINA NGUYEN Notes on a crazy 36 hours, brinkmanship, Ted Cruz, and a bewildered Ukrainian premier. JULIA IOFFE Notes on Peloton’s market value collapse, Netflix’s future, M&A arbitrage, and Apollo’s next potential pound of flesh. WILLIAM D. COHAN
|
SHARE



